Evidence map›Paper›PMID 29292740›Full record

ArticleMolecules (Basel, Switzerland)2017

Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation.

Hongkai Wang, Yingxia Zhang, Zhongjing Tian, Jing Ma, Meiling Kang, Chengshi Ding, Dongfeng Ming

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hongkai WangCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. whk62@126.com.
Yingxia ZhangCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. yingxiazh@126.com.
Zhongjing TianCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. jingzt03@163.com.
Jing MaCollege of Medical Science, Zaozhuang Vocational College, Zaozhuang 277800, China. ma_haiming@163.com.
Meiling KangCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. kmling006@126.com.
Chengshi DingCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. dingchengshi@uzz.edu.cn.
Dongfeng MingCollege of Life Science, Zaozhuang University, Zaozhuang 277160, China. mingdongfeng@uzz.edu.cn.
Zaozhuang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this study, β-cyclodextrin (β-CD) was chosen as the coating for ellagic acid to prepare ellagic acid microspheres, and the effect of microspheres on the growth of HepG2 cells was observed.

methodsScanning electron microscopy, infrared spectroscopy, and release rate analysis were used to identify the formation of ellagic acid microspheres. Methyl thiazolyl tetrazolium (MTT) assay was used to detect the effect of different concentrations of ellagic acid microspheres on tumor cell proliferation at 6, 12, 24 and 36 h, and cell morphology and quantity were observed using hematoxylin-eosin (HE) staining. Single-cell gel electrophoresis was used to observe the effect of ellagic acid microspheres on the DNA damage of HepG2 cells, and the Olive tail moment and the mRNA expression of tumor suppressor protein gene p53 was measured.

resultsβ-CD could be used as wrapping material of ellagic acid to prepare ellagic acid microspheres. HepG2 cell proliferation could be inhibited by 0.1, 0.3 and 0.5 g/L of ellagic acid microspheres in a dose- and time-dependent manner, and the mechanism of proliferation inhibition was related to DNA damage and cell apoptosis.

conclusionPreparing ellagic acid microspheres with β-CD is feasible, and ellagic acid microspheres have potential therapeutic value (anticancer).

Indexed as

MicrospheresAntineoplastic AgentsApoptosisbeta-CyclodextrinsCell ProliferationCell SurvivalDNA DamageDose-Response Relationship, DrugDrug CarriersDrug LiberationEllagic AcidHep G2 CellsHumansKineticsParticle SizeSurface PropertiesAntineoplastic Agentsbeta-CyclodextrinsbetadexDrug CarriersEllagic AcidTumor Suppressor Protein p53HepG2 cell proliferationsidentificationpreparationβ-CD-ellagic acid microspheres

Identifiers

PMID29292740
PMCPMC6149914
OpenAlexW2775519199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.